However, in a phase of cancer progression where TSGA10 is downregulated (e.g., glioblastoma), perhaps under HIF-1α pressure, disrupted coupling at Complex III may promote electron leakage, elevating ROS to mutagenic levels that drive oncogenic mutations. Here, TSGA10 is linked to cancer.